Update on U.K. standards work
This article was originally published in The Gray Sheet
Executive Summary
Medicines and Healthcare Regulatory Agency is negotiating funding with the Department of Health to resume limited participation with medical device standards work during the 2009/10 financial year, according to an Aug. 4 statement (1"The Gray Sheet" Aug. 4, 2008, p. 24). "If funding becomes available, its involvement will be limited to the provision of technical expertise only to those standards committees where there is a benefit to the safety of medical devices," the agency underscores
You may also be interested in...
U.K. Regulatory Agency Prioritizes Safety Over International Standards Work
The U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has turned its focus away from international standards work to concentrate instead on investigating medical device safety issues
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.